European Journal of Internal Medicine
Volume 14, Issue 4 , Pages 249-254, July 2003

Fever of unknown origin—predictors of outcome:

A prospective multicenter study on 164 patients

  • Cristian Baicus

      Affiliations

    • Spitalul Colentina, Medicala B, Soseaua Stefan cel Mare 19–21, sect. 2, 72202 Bucharest, Romania
    • Clinical Research Unit RECIF (Réseau d’Epidémiologie Clinique International Francophone), Bucharest, Romania
    • Corresponding Author InformationCorresponding author.
  • ,
  • Horatiu D Bolosiu

      Affiliations

    • Department of Internal Medicine, Cluj County Hospital, Cluj, Romania
  • ,
  • Coman Tanasescu

      Affiliations

    • Spitalul Colentina, Medicala B, Soseaua Stefan cel Mare 19–21, sect. 2, 72202 Bucharest, Romania
  • ,
  • Anda Baicus

      Affiliations

    • I. Cantacuzino Microbiology Institute, Bucharest, Romania
  • ,
  • for the GSFONR

      Affiliations

    • Grupul pentru Studiul Febrei de Origine Necunoscuta in Romania (The Group for the Study of the Fever of Unknown Origin in Romania): Bucharest: C. Baicus, C. Tanasescu, I. Matei, A. Haidar, R. Voiosu, Colentina Hospital; E. Ceausu, P. Calistru, C. Cristea, Infectious Diseases Hospital; A. Baicus, I. Cantacuzino Microbiology Institute; Cluj: H. Bolosiu, M. Stoicescu, County Hospital; Iasi: V. Luca, Infectious Diseases Hospital; A. Cosovanu, St. Spiridon Hospital; Timisoara: D. Stanescu, Infectious Diseases Hospital; Sibiu: M. Deac, C. Beca, C. Cipaian, M. Grecu, D. Vulcu, County Hospital; Brasov: E. Gheorghita, I. Brumaru, G. Vulcan, County Hospital; Targu Mures: E. Carasca, D. Pop Petre, County Hospital.

Received 25 November 2002; received in revised form 20 February 2003; accepted 11 March 2003.

Abstract 

Background: To date, the studies that have been done on fever of unknown origin have mostly been descriptive. Therefore, we know the etiogical spectrum and how it has changed since 1966 for many regions of the world. However, we do not know if there are clinical or laboratory predictors of severe outcome. Being able to estimate the severity of the disease early on would allow one to determine how intensive the diagnostic work-up should be. Methods: A multicenter cohort study was carried out on 164 consecutive patients who met the classic, modified criteria of fever of unknown origin. The study lasted 2 years (1997–1998) and included a follow-up period of another 2 years. The main outcome measured was the final diagnosis established at the end of follow-up. Results: When the white cell count was abnormal, the relative risk for a serious disease was 1.49 (CI: 1.15–1.94; p=0.004), when anemia was present, the relative risk was 1.55 (CI: 1.21–1.98; p=0.003), and for high alanine aminotransferase (ALAT), bilirubin, or lactate dehydrogenase (LDH), the relative risks were 1.57 (CI: 1.21–2.02; p=0.010), 1.57 (CI: 1.18–2.08; p=0.007), and 3.43 (CI: 1.81–6.48; p=0.0002), respectively. In multivariate analysis, the odds ratios for serious diseases were 2.7 (CI: 1.17–6.4; p=0.02) for abnormal white cell count, 2.8 (CI: 1.14–7.16; p=0.02) for anemia, 4.3 (CI: 1.6–11.5; p=0.003) for high serum bilirubin, and 5.3 (1.5–18.6; p=0.009) for high serum ALAT. Conclusions: In patients having a fever of unknown origin, anemia, abnormal white cell count, and high ALAT and bilirubin are independent predictors of severe outcome.

Keywords:  Multicenter cohort study, Prognosis, Fever of unknown origin, Bilirubin, Alanine aminotransferase, Lactate dehydrogenase, Anemia, Leukocytosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(03)00075-X

doi:10.1016/S0953-6205(03)00075-X

European Journal of Internal Medicine
Volume 14, Issue 4 , Pages 249-254, July 2003